PICK A TIME SLOT
₹ Price not available
Malleshwaram - Bengaluru
₹
You will receive an SMS with a verification code on this number.
Are you new to hospital ?
We have sent you an OTP on
Resend OTP
Did not receive OTP? You can request for another OTP. Click on Resend OTP
Go Back
Your appointment is
confirmed.
The details will be shared via Email & SMS
Note :Temporary visitor restriction, only one attendant is permitted with the patient. Your cooperation is solicited.
Dr. Rudresha AH is an accomplished consultant in Medical Oncology at Manipal Hospital, located in Malleshwaram, Bengaluru. His impressive educational background includes an MBBS degree from JJMMC in Davanagere, followed by an MD in Internal Medicine from KIMS in Hubli. Driven by his passion for oncology, he further pursued a DM in Medical Oncology from KIMS Oncology, solidifying his expertise in the field. Dr. Rudresha AH possesses a diverse range of skills, specialising in both medical oncology and internal medicine. His fluency in Kannada, English, and Hindi enables him to effectively communicate with a broad spectrum of patients, fostering understanding and facilitating optimal care. As an active contributor to the medical community, Dr. Rudresha AH has made notable presentations and publications. He has showcased his knowledge and expertise at esteemed conferences and workshops across the country and internationally. Some of his remarkable presentations include participation in the 17th National CME in Hematology held in Mumbai and the Toxicity Management in LAHNC conference in Bangalore. At the Basic GCP Workshop held in Bangalore, Dr. Rudresha AH took the opportunity to share his valuable insights into Good Clinical Practice (GCP). GCP serves as a crucial set of ethical and scientific standards that guide the design, conduct, and reporting of clinical trials. By participating in this workshop, Dr. Rudresha AH demonstrated his commitment to upholding the highest standards of research integrity and patient safety. He is an acclaimed oncology specialist in Bangalore.
- Furthermore, he made significant contributions to the International Conference on Haemato-oncology in August 2011, the Lymphomas and Leukemias 2012 European School of Oncology, the 3rd Asian Breast Cancer Congress in March 2012, and the Best of ASCO 12 in June 2012. In addition to his presentations, Dr. Rudresha AH has actively published papers in renowned medical journals. His notable contributions include a prospective study focusing on the efficacy and toxicity of 5-fluorouracil and cisplatin versus Taxane and Cisplatin as induction chemotherapy in locally advanced head and neck squamous cell cancer. This groundbreaking study was conducted in a regional cancer centre in India, shedding light on optimal treatment approaches for this challenging condition. Furthermore, Dr. Rudresha AH published a remarkable case study detailing a rare occurrence of oral synovial sarcoma in a child, which was accepted by the International Journal of Surgical Oncology (IJSO). Dr. Rudresha AH's impressive qualifications, extensive experience, and significant contributions to the field of oncology solidify his position as a leading consultant in Medical Oncology. His dedication to improving patient care, coupled with his ongoing involvement in research and education, makes him an invaluable asset to Manipal Hospital and the medical community as a whole.
- Medical Oncology
- Internal medicine
- Kannada
- English
- Hindi
- 17th national CME in Hematology, 27-Jan-2011, Mumbai
- Toxicity Management IN LAHNC, 19-March-2011, Bangalore
- Basic GCP Workshop, 14th March 2011, Bangalore.
- International conference On Haemato Oncology 5th August 2011.
- Lymphomas and leukaemia’s 2012, European school of oncology 8th June 2012.
- 3rd Asian Breast cancer Congress, 4-March-2012, Bangalore.
- Best of ASCO 12, 22-June-Jaipur.
- A prospective study to assess the efficacy and toxicity of 5-fluorouracil and cisplatin(PF).
- Versus Taxane and Cisplatin (TP) as induction chemotherapy in locally advanced head and neck.
- Squamous cell cancer in a regional cancer centre in India Accepted for publication.
- Oral synovial Sarcoma In a child -A rare case Accepted in IJSO.
Overview
Field of Expertise
Languages Spoken
Talks & Publications
- Kannada
- English
- Hindi
Dr. Rudresha AH is an accomplished consultant in Medical Oncology at Manipal Hospital, located in Malleshwaram, Bengaluru. His impressive educational background includes an MBBS degree from JJMMC in Davanagere, followed by an MD in Internal Medicine from KIMS in Hubli. Driven by his passion for oncology, he further pursued a DM in Medical Oncology from KIMS Oncology, solidifying his expertise in the field. Dr. Rudresha AH possesses a diverse range of skills, specialising in both medical oncology and internal medicine. His fluency in Kannada, English, and Hindi enables him to effectively communicate with a broad spectrum of patients, fostering understanding and facilitating optimal care. As an active contributor to the medical community, Dr. Rudresha AH has made notable presentations and publications. He has showcased his knowledge and expertise at esteemed conferences and workshops across the country and internationally. Some of his remarkable presentations include participation in the 17th National CME in Hematology held in Mumbai and the Toxicity Management in LAHNC conference in Bangalore. At the Basic GCP Workshop held in Bangalore, Dr. Rudresha AH took the opportunity to share his valuable insights into Good Clinical Practice (GCP). GCP serves as a crucial set of ethical and scientific standards that guide the design, conduct, and reporting of clinical trials. By participating in this workshop, Dr. Rudresha AH demonstrated his commitment to upholding the highest standards of research integrity and patient safety. He is an acclaimed oncology specialist in Bangalore.
- Furthermore, he made significant contributions to the International Conference on Haemato-oncology in August 2011, the Lymphomas and Leukemias 2012 European School of Oncology, the 3rd Asian Breast Cancer Congress in March 2012, and the Best of ASCO 12 in June 2012. In addition to his presentations, Dr. Rudresha AH has actively published papers in renowned medical journals. His notable contributions include a prospective study focusing on the efficacy and toxicity of 5-fluorouracil and cisplatin versus Taxane and Cisplatin as induction chemotherapy in locally advanced head and neck squamous cell cancer. This groundbreaking study was conducted in a regional cancer centre in India, shedding light on optimal treatment approaches for this challenging condition. Furthermore, Dr. Rudresha AH published a remarkable case study detailing a rare occurrence of oral synovial sarcoma in a child, which was accepted by the International Journal of Surgical Oncology (IJSO). Dr. Rudresha AH's impressive qualifications, extensive experience, and significant contributions to the field of oncology solidify his position as a leading consultant in Medical Oncology. His dedication to improving patient care, coupled with his ongoing involvement in research and education, makes him an invaluable asset to Manipal Hospital and the medical community as a whole.
- Medical Oncology
- Internal medicine
- 17th national CME in Hematology, 27-Jan-2011, Mumbai
- Toxicity Management IN LAHNC, 19-March-2011, Bangalore
- Basic GCP Workshop, 14th March 2011, Bangalore.
- International conference On Haemato Oncology 5th August 2011.
- Lymphomas and leukaemia’s 2012, European school of oncology 8th June 2012.
- 3rd Asian Breast cancer Congress, 4-March-2012, Bangalore.
- Best of ASCO 12, 22-June-Jaipur.
- A prospective study to assess the efficacy and toxicity of 5-fluorouracil and cisplatin(PF).
- Versus Taxane and Cisplatin (TP) as induction chemotherapy in locally advanced head and neck.
- Squamous cell cancer in a regional cancer centre in India Accepted for publication.
- Oral synovial Sarcoma In a child -A rare case Accepted in IJSO.
Languages Spoken
Overview
Field of Expertise
Talks & Publications
- Medical Oncology
- Internal medicine
- Kannada
- English
- Hindi
- 17th national CME in Hematology, 27-Jan-2011, Mumbai
- Toxicity Management IN LAHNC, 19-March-2011, Bangalore
- Basic GCP Workshop, 14th March 2011, Bangalore.
- International conference On Haemato Oncology 5th August 2011.
- Lymphomas and leukaemia’s 2012, European school of oncology 8th June 2012.
- 3rd Asian Breast cancer Congress, 4-March-2012, Bangalore.
- Best of ASCO 12, 22-June-Jaipur.
- A prospective study to assess the efficacy and toxicity of 5-fluorouracil and cisplatin(PF).
- Versus Taxane and Cisplatin (TP) as induction chemotherapy in locally advanced head and neck.
- Squamous cell cancer in a regional cancer centre in India Accepted for publication.
- Oral synovial Sarcoma In a child -A rare case Accepted in IJSO.
Dr. Rudresha AH is an accomplished consultant in Medical Oncology at Manipal Hospital, located in Malleshwaram, Bengaluru. His impressive educational background includes an MBBS degree from JJMMC in Davanagere, followed by an MD in Internal Medicine from KIMS in Hubli. Driven by his passion for oncology, he further pursued a DM in Medical Oncology from KIMS Oncology, solidifying his expertise in the field. Dr. Rudresha AH possesses a diverse range of skills, specialising in both medical oncology and internal medicine. His fluency in Kannada, English, and Hindi enables him to effectively communicate with a broad spectrum of patients, fostering understanding and facilitating optimal care. As an active contributor to the medical community, Dr. Rudresha AH has made notable presentations and publications. He has showcased his knowledge and expertise at esteemed conferences and workshops across the country and internationally. Some of his remarkable presentations include participation in the 17th National CME in Hematology held in Mumbai and the Toxicity Management in LAHNC conference in Bangalore. At the Basic GCP Workshop held in Bangalore, Dr. Rudresha AH took the opportunity to share his valuable insights into Good Clinical Practice (GCP). GCP serves as a crucial set of ethical and scientific standards that guide the design, conduct, and reporting of clinical trials. By participating in this workshop, Dr. Rudresha AH demonstrated his commitment to upholding the highest standards of research integrity and patient safety. He is an acclaimed oncology specialist in Bangalore.
- Furthermore, he made significant contributions to the International Conference on Haemato-oncology in August 2011, the Lymphomas and Leukemias 2012 European School of Oncology, the 3rd Asian Breast Cancer Congress in March 2012, and the Best of ASCO 12 in June 2012. In addition to his presentations, Dr. Rudresha AH has actively published papers in renowned medical journals. His notable contributions include a prospective study focusing on the efficacy and toxicity of 5-fluorouracil and cisplatin versus Taxane and Cisplatin as induction chemotherapy in locally advanced head and neck squamous cell cancer. This groundbreaking study was conducted in a regional cancer centre in India, shedding light on optimal treatment approaches for this challenging condition. Furthermore, Dr. Rudresha AH published a remarkable case study detailing a rare occurrence of oral synovial sarcoma in a child, which was accepted by the International Journal of Surgical Oncology (IJSO). Dr. Rudresha AH's impressive qualifications, extensive experience, and significant contributions to the field of oncology solidify his position as a leading consultant in Medical Oncology. His dedication to improving patient care, coupled with his ongoing involvement in research and education, makes him an invaluable asset to Manipal Hospital and the medical community as a whole.
Field of Expertise
Languages Spoken
Talks & Publications
Overview
- 17th national CME in Hematology, 27-Jan-2011, Mumbai
- Toxicity Management IN LAHNC, 19-March-2011, Bangalore
- Basic GCP Workshop, 14th March 2011, Bangalore.
- International conference On Haemato Oncology 5th August 2011.
- Lymphomas and leukaemia’s 2012, European school of oncology 8th June 2012.
- 3rd Asian Breast cancer Congress, 4-March-2012, Bangalore.
- Best of ASCO 12, 22-June-Jaipur.
- A prospective study to assess the efficacy and toxicity of 5-fluorouracil and cisplatin(PF).
- Versus Taxane and Cisplatin (TP) as induction chemotherapy in locally advanced head and neck.
- Squamous cell cancer in a regional cancer centre in India Accepted for publication.
- Oral synovial Sarcoma In a child -A rare case Accepted in IJSO.
Dr. Rudresha AH is an accomplished consultant in Medical Oncology at Manipal Hospital, located in Malleshwaram, Bengaluru. His impressive educational background includes an MBBS degree from JJMMC in Davanagere, followed by an MD in Internal Medicine from KIMS in Hubli. Driven by his passion for oncology, he further pursued a DM in Medical Oncology from KIMS Oncology, solidifying his expertise in the field. Dr. Rudresha AH possesses a diverse range of skills, specialising in both medical oncology and internal medicine. His fluency in Kannada, English, and Hindi enables him to effectively communicate with a broad spectrum of patients, fostering understanding and facilitating optimal care. As an active contributor to the medical community, Dr. Rudresha AH has made notable presentations and publications. He has showcased his knowledge and expertise at esteemed conferences and workshops across the country and internationally. Some of his remarkable presentations include participation in the 17th National CME in Hematology held in Mumbai and the Toxicity Management in LAHNC conference in Bangalore. At the Basic GCP Workshop held in Bangalore, Dr. Rudresha AH took the opportunity to share his valuable insights into Good Clinical Practice (GCP). GCP serves as a crucial set of ethical and scientific standards that guide the design, conduct, and reporting of clinical trials. By participating in this workshop, Dr. Rudresha AH demonstrated his commitment to upholding the highest standards of research integrity and patient safety. He is an acclaimed oncology specialist in Bangalore.
- Furthermore, he made significant contributions to the International Conference on Haemato-oncology in August 2011, the Lymphomas and Leukemias 2012 European School of Oncology, the 3rd Asian Breast Cancer Congress in March 2012, and the Best of ASCO 12 in June 2012. In addition to his presentations, Dr. Rudresha AH has actively published papers in renowned medical journals. His notable contributions include a prospective study focusing on the efficacy and toxicity of 5-fluorouracil and cisplatin versus Taxane and Cisplatin as induction chemotherapy in locally advanced head and neck squamous cell cancer. This groundbreaking study was conducted in a regional cancer centre in India, shedding light on optimal treatment approaches for this challenging condition. Furthermore, Dr. Rudresha AH published a remarkable case study detailing a rare occurrence of oral synovial sarcoma in a child, which was accepted by the International Journal of Surgical Oncology (IJSO). Dr. Rudresha AH's impressive qualifications, extensive experience, and significant contributions to the field of oncology solidify his position as a leading consultant in Medical Oncology. His dedication to improving patient care, coupled with his ongoing involvement in research and education, makes him an invaluable asset to Manipal Hospital and the medical community as a whole.
- Medical Oncology
- Internal medicine
- Kannada
- English
- Hindi
Talks & Publications
Overview
Field of Expertise
Languages Spoken
Refund Policy
1) Up to 4 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation can be done with full refund of the payment.
2) Up to 2 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation of appointment and refund with a cancellation charge of Rs.100/-.
3) Less than 2 hrs of appointment time:
Rescheduling / cancellation of appointment cannot be done, payment non-refundable in this case. However, Units can have the discretion to refund / reschedule in case of exigencies.
Please note : While making the payment online, above mentioned payment terms and conditions should be agreed upon by customers, by clicking in a box ( I agree) and then proceed for payment.
PATIENT CONSENT FOR TELEMEDICINE / TELECONSULTATION
Telemedicine involves the use of electronic communications to enable Hospitals/health care centres to provide healthcare services at different locations through exchange of information and for the purpose of improving patient care. I, confirm that I have received the necessary information to sign this form and I agree to take part in a live telemedicine/teleconsultation session with Manipal Hospitals.
I understand that:
- Interactive audio/video connection, electronic information and communication technologies shall be used for providing me with a telemedicine/teleconsultation.
- In case the information obtained via teleconsultation is not sufficient to make a diagnosis, I may be required to go to Manipal Hospitals for in-person consultation.
- Though the telemedicine/teleconsultation is private, other individuals, medical and non-medical, may be present to facilitate the consultation and that they will take reasonable steps to maintain confidentiality of the information obtained.
- A limited visual examination will take place during the telemedicine/teleconsultation and that it cannot replace a full medical examination done physically at Manipal Hospitals.
- I have the right to withhold or withdraw my consent to the use of telemedicine/teleconsultation in the course of my care at any time, without affecting my right to future care or treatment. I may also revoke my consent orally or in writing at any time.
- I may be prescribed medicines for treatment or/and diagnostic tests to further evaluate my health condition. All prescription will be sent to my registered email/phone no. Manipal Hospitals will keep a record of the consultation & prescription in my medical record.
- The telemedicine/teleconsultation services are not in any way intended to be used in case of an emergency.
- There can be potential risks with this technology e.g information transmitted may not be sufficient to allow for appropriate medical decision, the video /audio may disconnect/stop in-between, security protocols could fail causing a breach of privacy of personal medical information.
- Any relevant medical information about me including details of my medical history, examinations, x-rays, tests, photographs or other images may be transmitted /shared by Manipal Hospitals with their staff, specialist, business partners for the purpose of record, communications, feedback, enquires, follow ups, analysis etc.
- Manipal Hospitals responsibility shall terminate upon conclusion of this teleconference.
- I hereby consent that in consideration for the telemedicine / teleconsultation services rendered to me, I agree to pay the relevant charges.
- I hereby release Manipal Hospitals, its personnel and any other person participating in my care from any and all liability which may arise from authorized use of such Video / E-Consultation, Videotapes, Digital recording films and Photographs. I have read this document and understand the risk of the telemedicine / teleconsultation.
- I hereby consent to participate in a telemedicine / teleconsultation under the terms & conditions described in this document.
